Cowen Inc’s Sutro Biopharma STRO Stock Holding History

Cowen Inc’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-41,732	Closed	-$6.26M	–	479
2018 Q3	$6.26M	Buy	+41,732	New	+$6.3M	0.57%	46

Other funds holding STRO

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Cowen Inc's STRO Position: Q4 2018 in Review

Cowen Inc sold out of Sutro Biopharma (STRO) in Q4 2018, closing a stake of 41,732 shares — an estimated $6.26M sold.

Cowen Inc first reported a position in STRO in Q3 2018 and held it in 1 quarter. The position peaked at $6.26M in Q3 2018. 43 funds tracked by Wall St. Rank hold STRO as of Q4 2018.

Cowen Inc reported no remaining Sutro Biopharma position as of Q4 2018 after selling out during the quarter.
Cowen Inc sold 41,732 Sutro Biopharma shares in Q4 2018, an estimated $6.26M.
Cowen Inc first reported a position in Sutro Biopharma in Q3 2018 and held it in 1 quarter.
Cowen Inc's Sutro Biopharma position peaked at $6.26M in Q3 2018.
43 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2018.

Based on Cowen Inc's 13F filing for Q4 2018, filed 14 Feb 2019.